应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LENZ Therapeutics
盘前交易 07-23 06:20:42 EDT
32.98
-0.60
-1.79%
最高
34.11
最低
32.72
成交量
11.61万
今开
33.75
昨收
33.58
日振幅
4.15%
总市值
9.28亿
流通市值
4.20亿
总股本
2,815万
成交额
386.37万
换手率
0.91%
流通股本
1,273万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Windtree Therapeutics, Inc.7月22日成交额为796.07万美元
市场透视 · 07:48
Windtree Therapeutics, Inc.7月22日成交额为796.07万美元
Vyne Therapeutics Inc.7月22日成交额为62.43万美元
市场透视 · 07:36
Vyne Therapeutics Inc.7月22日成交额为62.43万美元
Crispr Therapeutics Ag7月22日成交额为2.72亿美元
市场透视 · 01:43
Crispr Therapeutics Ag7月22日成交额为2.72亿美元
Alterity Therapeutics Limited7月22日成交额为8.54万美元
市场透视 · 01:18
Alterity Therapeutics Limited7月22日成交额为8.54万美元
Windtree Therapeutics, Inc.7月21日成交额为1307.49万美元
市场透视 · 07-22 07:34
Windtree Therapeutics, Inc.7月21日成交额为1307.49万美元
Vyne Therapeutics Inc.7月21日成交额为127.16万美元
市场透视 · 07-22 07:21
Vyne Therapeutics Inc.7月21日成交额为127.16万美元
Mink Therapeutics, Inc.7月21日成交额为1060.76万美元
市场透视 · 07-22 02:52
Mink Therapeutics, Inc.7月21日成交额为1060.76万美元
Sarepta Therapeutics(SRPT)挫逾4% FDA要求下架其治疗肌肉萎缩症药物
金吾财讯 · 07-21 14:39
Sarepta Therapeutics(SRPT)挫逾4% FDA要求下架其治疗肌肉萎缩症药物
超4.75亿美元!iTeos Therapeutics宣布关门后被收购
Medaverse · 07-21 13:40
超4.75亿美元!iTeos Therapeutics宣布关门后被收购
Vyne Therapeutics Inc.7月18日成交额为88.67万美元
市场透视 · 07-19
Vyne Therapeutics Inc.7月18日成交额为88.67万美元
Entero Therapeutics Inc.7月18日成交额为12.23万美元
市场透视 · 07-19
Entero Therapeutics Inc.7月18日成交额为12.23万美元
Sarepta Therapeutics股价大跌36%
DoNews · 07-18
Sarepta Therapeutics股价大跌36%
Crispr Therapeutics Ag7月17日成交额为1.22亿美元
市场透视 · 07-18
Crispr Therapeutics Ag7月17日成交额为1.22亿美元
Alterity Therapeutics Limited7月17日成交额为17.08万美元
市场透视 · 07-18
Alterity Therapeutics Limited7月17日成交额为17.08万美元
Bicycle Therapeutics Plc盘中异动 下午盘股价大涨5.14%
市场透视 · 07-17
Bicycle Therapeutics Plc盘中异动 下午盘股价大涨5.14%
Monte Rosa Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报5.90美元
市场透视 · 07-17
Monte Rosa Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报5.90美元
Lisata Therapeutics, Inc.盘中异动 股价大跌5.84%
市场透视 · 07-17
Lisata Therapeutics, Inc.盘中异动 股价大跌5.84%
Outlook Therapeutics, Inc.盘中异动 快速跳水5.39%报2.28美元
市场透视 · 07-17
Outlook Therapeutics, Inc.盘中异动 快速跳水5.39%报2.28美元
Jasper Therapeutics, Inc.盘中异动 股价大涨5.07%
市场透视 · 07-17
Jasper Therapeutics, Inc.盘中异动 股价大涨5.07%
Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.93%
市场透视 · 07-17
Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.93%
加载更多
公司概况
公司名称:
Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立,并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司,利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法,以实现医学上最难以实现的目标之一:精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变,用正常基因替换整个致病基因,或将新基因插入预定的安全位置。
发行价格:
--
{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":32.98,"timestamp":1753214400000,"preClose":33.58,"halted":0,"volume":116129,"delay":0,"floatShares":12729900,"shares":28146154,"eps":-1.769251,"marketStatus":"盘前交易","change":-0.6,"latestTime":"07-23 06:20:42 EDT","open":33.75,"high":34.11,"low":32.715,"amount":3863700.08804,"amplitude":0.041543,"askPrice":52.76,"askSize":200,"bidPrice":32.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753277400000},"marketStatusCode":1,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":32.98,"postHourTrading":{"tag":"盘后","latestPrice":32.98,"preClose":32.98,"latestTime":"19:48 EDT","volume":1827,"amount":60286.46,"timestamp":1753228132584},"volumeRatio":0.3930529917827531,"impliedVol":1.0166,"impliedVolPercentile":0.9014},"requestUrl":"/m/hq/s/LENZ","defaultTab":"news","newsList":[{"id":"2553297245","title":"Windtree Therapeutics, Inc.7月22日成交额为796.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553297245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553297245?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:48","pubTimestamp":1753256917,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,Windtree Therapeutics, Inc.成交额为796.07万美元,成交额较昨日减少39.12%,当日成交量为809.48万股。Windtree Therapeutics, Inc.于2025年7月22日涨1.01%,报1.0美元,该股过去5个交易日涨20.63%,年初至今跌94.27%,过去60日跌14.53%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-22|796.07万|-39.12%|809.48万|#|2025-07-21|1307.49万|-44.97%|1244.28万|#|2025-07-18|2375.90万|-86.82%|1949.72万|#|2025-07-17|1.80亿|342.39%|1.28亿|#|2025-07-16|4075.58万|277.08%|4974.34万|Windtree Therapeutics Inc 是一家生物技术公司,专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723160925a6bcc7c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723160925a6bcc7c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","WINTW","BK4539","WINT","BK4139","BK4007"],"gpt_icon":1},{"id":"2553218606","title":"Vyne Therapeutics Inc.7月22日成交额为62.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553218606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553218606?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:36","pubTimestamp":1753256186,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,Vyne Therapeutics Inc.成交额为62.43万美元,成交额较昨日减少50.90%,当日成交量为54.15万股。Vyne Therapeutics Inc.于2025年7月22日跌7.44%,报1.12美元,该股过去5个交易日跌13.18%,年初至今跌66.57%,过去60日跌40.43%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-22|62.43万|-50.90%|54.15万|#|2025-07-21|127.16万|43.41%|108.21万|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|#|2025-07-16|37.42万|7.01%|29.24万|VYNE Therapeutics Inc 是一家生物制药公司,专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723154915a45e44fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723154915a45e44fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","VYNE","BK4539"],"gpt_icon":0},{"id":"2553267141","title":"Crispr Therapeutics Ag7月22日成交额为2.72亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553267141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553267141?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:43","pubTimestamp":1753234987,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,Crispr Therapeutics Ag成交额为2.72亿美元,成交额较昨日减少43.79%,当日成交量为420.56万股。Crispr Therapeutics Ag于2025年7月22日涨0.92%,报65.93美元,该股过去5个交易日涨25.03%,年初至今涨67.51%,过去60日涨68.58%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写,是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy,它是与Vertex制药公司合作开发的,主要针对镰状细胞病和输血依赖型β-地中海贫血,这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094313a6bc1128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094313a6bc1128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LU1861559042.SGD","BK4611","CRSP","LENZ","BK4588","BK4007","BK4556","BK4139","LU1861558580.USD","BK4585"],"gpt_icon":1},{"id":"2553262436","title":"Alterity Therapeutics Limited7月22日成交额为8.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553262436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553262436?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:18","pubTimestamp":1753233525,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日,Alterity Therapeutics Limited成交额为8.54万美元,成交额较昨日减少72.91%,当日成交量为1.67万股。Alterity Therapeutics Limited于2025年7月22日涨5.31%,报5.16美元,该股过去5个交易日涨15.44%,年初至今涨55.89%,过去60日涨45.76%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-22|8.54万|-72.91%|1.67万|#|2025-07-21|31.51万|-79.73%|6.42万|#|2025-07-18|155.46万|810.19%|30.30万|#|2025-07-17|17.08万|-10.06%|3.66万|#|2025-07-16|18.99万|5.21%|4.10万|Alterity Therapeutics Ltd 活跃在医疗保健领域。该集团经营单一的部门,即帕金森病和其他神经退行性疾病的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723091852a45d8515&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723091852a45d8515&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRNAF","ATHE","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2553023808","title":"Windtree Therapeutics, Inc.7月21日成交额为1307.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553023808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553023808?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:34","pubTimestamp":1753169677,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日,Windtree Therapeutics, Inc.成交额为1307.49万美元,成交额较昨日减少44.97%,当日成交量为1244.28万股。Windtree Therapeutics, Inc.于2025年7月21日跌16.81%,报0.99美元,该股过去5个交易日涨25.32%,年初至今跌94.33%,过去60日跌12.39%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-21|1307.49万|-44.97%|1244.28万|#|2025-07-18|2375.90万|-86.82%|1949.72万|#|2025-07-17|1.80亿|342.39%|1.28亿|#|2025-07-16|4075.58万|277.08%|4974.34万|#|2025-07-15|1080.83万|-84.71%|1342.16万|Windtree Therapeutics Inc 是一家生物技术公司,专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722154735a45bae1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722154735a45bae1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","WINTW","LENZ","WINT","BK4007"],"gpt_icon":1},{"id":"2553871082","title":"Vyne Therapeutics Inc.7月21日成交额为127.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553871082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553871082?lang=zh_cn&edition=full","pubTime":"2025-07-22 15:21","pubTimestamp":1753168898,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日,Vyne Therapeutics Inc.成交额为127.16万美元,成交额较昨日增加43.41%,当日成交量为108.21万股。Vyne Therapeutics Inc.于2025年7月21日涨4.31%,报1.21美元,该股过去5个交易日跌9.02%,年初至今跌63.88%,过去60日跌34.24%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-21|127.16万|43.41%|108.21万|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|#|2025-07-16|37.42万|7.01%|29.24万|#|2025-07-15|34.97万|-59.49%|26.58万|VYNE Therapeutics Inc 是一家生物制药公司,专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722152404a45b9d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722152404a45b9d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","BK4007","VYNE"],"gpt_icon":0},{"id":"2553286356","title":"Mink Therapeutics, Inc.7月21日成交额为1060.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553286356","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553286356?lang=zh_cn&edition=full","pubTime":"2025-07-22 10:52","pubTimestamp":1753152724,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日,Mink Therapeutics, Inc.成交额为1060.76万美元,成交额较昨日减少28.37%,当日成交量为51.87万股。Mink Therapeutics, Inc.于2025年7月21日跌2.51%,报19.8美元,该股过去5个交易日跌51.24%,年初至今涨184.07%,过去60日涨160.18%。该公司正在推进一系列原生和下一代工程iNKT项目,其平台旨在促进可扩展和可重复的制造,以实现现成的交付。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722105207a45b0b1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722105207a45b0b1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","BK4139","INKT"],"gpt_icon":0},{"id":"2553408316","title":"Sarepta Therapeutics(SRPT)挫逾4% FDA要求下架其治疗肌肉萎缩症药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2553408316","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553408316?lang=zh_cn&edition=full","pubTime":"2025-07-21 22:39","pubTimestamp":1753108775,"startTime":"0","endTime":"0","summary":"金吾财讯 | Sarepta Therapeutics(SRPT)股价走低,暂跌4.33%,报13.465美元。消息面上,公司一项未披露名称的疗法临床试验中出现一名患者死亡,该病例此前并未被报道。此外,FDA 还要求其将另一种疗法 Elevidys 下架。Sarepta拒绝了这一要求。这两种疗法都旨在治疗不同类型的肌肉萎缩症。分析师表示,管理层对此事的处理以及对 FDA 的蔑视使投资者陷入了“前所未有的境地”。Leerink 将该股评级下调至“与大盘持平”,并将目标价从 14 美元下调至 10 美元。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ZTgzYzFjMzMwYjg4MjEzNTY0MzUzNDIy.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZTgzYzFjMzMwYjg4MjEzNTY0MzUzNDIy.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"290652","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","SRPT","BK4539","IE0002141913.USD","IE0009355771.USD","BK4007","BK4585","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LENZ","IE00BJJMRZ35.SGD","BK4139"],"gpt_icon":0},{"id":"2553408163","title":"超4.75亿美元!iTeos Therapeutics宣布关门后被收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2553408163","media":"Medaverse","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553408163?lang=zh_cn&edition=full","pubTime":"2025-07-21 21:40","pubTimestamp":1753105206,"startTime":"0","endTime":"0","summary":"在iTeos管理层、法律和财务顾问的协助下进行了战略审查后,iTeos董事会一致决定,Concentra的收购符合所有iTeos股东的最佳利益,并批准了合并协议和相关交易。要约结束后,iTeos将立即被Concentra收购,要约中未投标的所有剩余股份,除iTeos、Concentra或其子公司或适当要求评估的持有人直接或间接拥有的股份外,将转换为每股iTeos普通股收取与要约中规定的相同要约对价的权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721225241a6b86a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721225241a6b86a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GSK","BK4007","BK4139","ITOS","LENZ","BK4539"],"gpt_icon":0},{"id":"2552341994","title":"Vyne Therapeutics Inc.7月18日成交额为88.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552341994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552341994?lang=zh_cn&edition=full","pubTime":"2025-07-19 14:57","pubTimestamp":1752908222,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日,Vyne Therapeutics Inc.成交额为88.67万美元,成交额较昨日增加44.95%,当日成交量为75.49万股。Vyne Therapeutics Inc.于2025年7月18日跌3.33%,报1.16美元,该股过去5个交易日跌18.31%,年初至今跌65.37%,过去60日跌37.63%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-18|88.67万|44.95%|75.49万|#|2025-07-17|61.17万|63.46%|49.20万|#|2025-07-16|37.42万|7.01%|29.24万|#|2025-07-15|34.97万|-59.49%|26.58万|#|2025-07-14|86.33万|-8.30%|64.50万|VYNE Therapeutics Inc 是一家生物制药公司,专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719145705a6b388df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719145705a6b388df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","BK4139","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2552415661","title":"Entero Therapeutics Inc.7月18日成交额为12.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552415661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552415661?lang=zh_cn&edition=full","pubTime":"2025-07-19 09:58","pubTimestamp":1752890292,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日,Entero Therapeutics Inc.成交额为12.23万美元,成交额较昨日减少28.06%,当日成交量为25.81万股。Entero Therapeutics Inc.于2025年7月18日跌0.08%,报0.473美元,该股过去5个交易日跌3.51%,年初至今跌23.99%,过去60日涨31.33%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-18|12.23万|-28.06%|25.81万|#|2025-07-17|17.00万|231.52%|36.55万|#|2025-07-16|5.13万|-45.27%|11.25万|#|2025-07-15|9.37万|-44.48%|20.65万|#|2025-07-14|16.87万|24.19%|35.85万|Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司,专注于开发针对胃肠道疾病的靶向非全身性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719095813a4548d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719095813a4548d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ENTO","BK4539"],"gpt_icon":0},{"id":"2552497028","title":"Sarepta Therapeutics股价大跌36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552497028","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552497028?lang=zh_cn&edition=full","pubTime":"2025-07-19 04:18","pubTimestamp":1752869882,"startTime":"0","endTime":"0","summary":"2025年7月19日,Sarepta Therapeutics Inc.(SRPT)股价收跌36%,创最近九年来收盘新低。市场分析认为,受制于其基因疗法商业化进程缓慢以及市场竞争加剧,公司股价遭遇大幅抛压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071904230897ab82c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071904230897ab82c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LENZ","SRPT","IE00BJJMRZ35.SGD","BK4539","IE0002141913.USD","BK4007","IE0009355771.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2552580214","title":"Crispr Therapeutics Ag7月17日成交额为1.22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552580214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552580214?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:41","pubTimestamp":1752802907,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日,Crispr Therapeutics Ag成交额为1.22亿美元,成交额较昨日减少33.00%,当日成交量为220.11万股。Crispr Therapeutics Ag于2025年7月17日跌0.09%,报55.09美元,该股过去5个交易日跌6.63%,年初至今涨39.96%,过去60日涨45.66%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写,是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy,它是与Vertex制药公司合作开发的,主要针对镰状细胞病和输血依赖型β-地中海贫血,这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094149a6b0e314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094149a6b0e314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4556","CRSP","LU1861559042.SGD","BK4585","BK4611","BK4539","BK4588","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2552320458","title":"Alterity Therapeutics Limited7月17日成交额为17.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552320458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552320458?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:18","pubTimestamp":1752801506,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日,Alterity Therapeutics Limited成交额为17.08万美元,成交额较昨日减少10.06%,当日成交量为3.66万股。Alterity Therapeutics Limited于2025年7月17日跌0.65%,报4.61美元,该股过去5个交易日涨18.51%,年初至今涨39.27%,过去60日涨33.62%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-17|17.08万|-10.06%|3.66万|#|2025-07-16|18.99万|5.21%|4.10万|#|2025-07-15|18.05万|-43.38%|3.96万|#|2025-07-14|31.88万|-90.19%|7.00万|#|2025-07-11|325.07万|2173.34%|65.94万|Alterity Therapeutics Ltd 活跃在医疗保健领域。该集团经营单一的部门,即帕金森病和其他神经退行性疾病的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091832a452235b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091832a452235b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATHE","BK4539","LENZ","PRNAF","BK4007"],"gpt_icon":0},{"id":"2552439148","title":"Bicycle Therapeutics Plc盘中异动 下午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439148?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:13","pubTimestamp":1752779622,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时13分,Bicycle Therapeutics Plc股票出现异动,股价急速上涨5.14%。Bicycle Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.29%。Bicycle Therapeutics Plc公司简介:Bicycle Therapeutics PLC 是一家临床阶段的生物制药公司,正在开发一种被称为 Bicycles 的新型药物。Bicycles 是合成的短肽,被限制形成两个环以稳定其结构几何形状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803134297aa214d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803134297aa214d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","BCYC"],"gpt_icon":0},{"id":"2552439101","title":"Monte Rosa Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报5.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439101?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:07","pubTimestamp":1752779260,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时07分,Monte Rosa Therapeutics, Inc.股票出现波动,股价快速拉升5.08%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Monte Rosa Therapeutics, Inc.公司简介:Monte Rosa Therapeutics Inc是一家生物技术公司,专门开发分子胶降解剂,这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803074097aa2030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803074097aa2030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLUE","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2552748019","title":"Lisata Therapeutics, Inc.盘中异动 股价大跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552748019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552748019?lang=zh_cn&edition=full","pubTime":"2025-07-17 23:19","pubTimestamp":1752765584,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时19分,Lisata Therapeutics, Inc.股票出现异动,股价急速下挫5.84%。Lisata Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Windtree Therapeutics, Inc.、Ovid Therapeutics Inc.涨幅较大,Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Imunon, Inc.较为活跃,换手率分别为903.86%、458.62%、211.28%,振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Clearside Biomedical, Inc.,振幅分别为148.12%、81.11%、61.99%。Lisata Therapeutics, Inc.公司简介:Lisata Therapeutics Inc是一家临床阶段的生物制药公司,致力于发现、开发和商业化用于治疗实体瘤和其他疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071723194497a9ef53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071723194497a9ef53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","LSTA"],"gpt_icon":0},{"id":"2552487713","title":"Outlook Therapeutics, Inc.盘中异动 快速跳水5.39%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552487713?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:39","pubTimestamp":1752763158,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时39分,Outlook Therapeutics, Inc.股票出现异动,股价急速跳水5.39%。Outlook Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃,换手率分别为870.62%、380.58%、188.31%,振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为148.12%、81.11%、61.18%。Outlook Therapeutics, Inc.公司简介:Outlook Therapeutics Inc 是一家临床阶段生物制药公司,专注于开发和商业化 ONS-5010,这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223918a4515e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223918a4515e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2552487732","title":"Jasper Therapeutics, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552487732?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:31","pubTimestamp":1752762675,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时31分,Jasper Therapeutics, Inc.股票出现异动,股价快速上涨5.07%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃,换手率分别为852.76%、348.88%、187.74%,振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为148.12%、81.11%、61.18%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223116a4515a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223116a4515a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2552482236","title":"Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482236?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:05","pubTimestamp":1752761130,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时05分,Werewolf Therapeutics, Inc.股票出现波动,股价快速拉升5.93%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Marker Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Windtree Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Immuron Limited、Abpro Holdings, Inc较为活跃,换手率分别为772.51%、185.16%、111.38%,振幅较大的相关个股有Marker Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Windtree Therapeutics, Inc.,振幅分别为98.74%、61.18%、56.67%。Werewolf Therapeutics, Inc.公司简介:Werewolf Therapeutics Inc 是一家生物制药公司,致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507172205309546413d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507172205309546413d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HOWL","LENZ","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.graphitebio.com","stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.1015},{"period":"3month","weight":0.2237},{"period":"6month","weight":0.332},{"period":"1year","weight":0.5005},{"period":"ytd","weight":0.1424}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0582},{"period":"3month","weight":0.1745},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.1338},{"period":"ytd","weight":0.073}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立,并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司,利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法,以实现医学上最难以实现的目标之一:精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变,用正常基因替换整个致病基因,或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.169631},{"month":2,"riseRate":0.5,"avgChangeRate":0.077415},{"month":3,"riseRate":0.25,"avgChangeRate":-0.098838},{"month":4,"riseRate":0.5,"avgChangeRate":-0.02248},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134416},{"month":6,"riseRate":0.75,"avgChangeRate":0.05507},{"month":7,"riseRate":0.6,"avgChangeRate":0.074984},{"month":8,"riseRate":0.25,"avgChangeRate":-0.053734},{"month":9,"riseRate":0.5,"avgChangeRate":-0.017856},{"month":10,"riseRate":0.75,"avgChangeRate":0.006056},{"month":11,"riseRate":0.5,"avgChangeRate":-0.013543},{"month":12,"riseRate":0.5,"avgChangeRate":0.070925}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}